You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Primary Biliary Cholangitis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Program for Primary Biliary Cholangitis Lost in the System

Recruiting
  • Primary Biliary Cholangitis
    • Terrassa, Barcelona, Spain
      Hospital Universitari MútuaTerrassa
    Jun 16, 2023

    Primary Biliary Cholangitis (PBC) Trial (Elafibranor, Matched 80 mg )

    Not yet recruiting
    • Primary Biliary Cholangitis (PBC)
    • (no location specified)
    Aug 29, 2023

    Primary Biliary Cholangitis (PBC) Trial in Shanghai (2mg CS0159, Placebo)

    Not yet recruiting
    • Primary Biliary Cholangitis (PBC)
    • 2mg CS0159
    • Placebo
    • Shanghai, Shanghai, China
      Renji Hospital, Shanghai Jiao Tong University School of Medicine
    Jun 7, 2023

    Primary Biliary Cholangitis Trial in Xi'an (Fenofibrate 200mg, Placebo, UDCA)

    Recruiting
    • Primary Biliary Cholangitis
    • Fenofibrate 200mg
    • +2 more
    • Xi'an, Shaanxi, China
      Xijing Hospital
    Mar 3, 2023

    Primary Biliary Cholangitis Trial in United States (Seladelpar 10 mg, Placebo)

    Recruiting
    • Primary Biliary Cholangitis
    • Seladelpar 10 mg
    • Placebo
    • Lancaster, California
    • +4 more
    Sep 26, 2023

    Primary Biliary Cholangitis Trial in United States (Seladelpar 10 mg, Placebo)

    Recruiting
    • Primary Biliary Cholangitis
    • Seladelpar 10 mg
    • Placebo
    • Chandler, Arizona
    • +3 more
    Oct 2, 2023

    Primary Biliary Cholangitis Trial in Xi'an (Placebo Combined With Ursodeoxycholic Acid, Fenofibrate Combined With

    Recruiting
    • Primary Biliary Cholangitis
    • Placebo Combined With Ursodeoxycholic Acid
    • Fenofibrate Combined With Ursodeoxycholic Acid
    • Xi'an, Shaanxi, China
      Ying han
    Mar 3, 2023

    Primary Biliary Cholangitis Trial in Beijing (Obeticholic Acid Tablets(OCA), UDCA, Placebo)

    Recruiting
    • Primary Biliary Cholangitis
    • Obeticholic Acid Tablets（OCA）
    • +2 more
    • Beijing, China
      Beijing Friendship Hospital
    Jul 7, 2022

    Pruritus Trial (Linerixibat)

    Available
    • Pruritus
    • (no location specified)
    Jul 1, 2022

    Evaluate Effectiveness of OCA on Hepatic Outcomes in PBC

    Enrolling by invitation
    • Primary Biliary Cholangitis
    • Obeticholic Acid 5 MG
    • +2 more
    • San Diego, California
      Intercept Pharmaceuticals, Inc
    Dec 15, 2022

    Primary Biliary Cirrhosis Trial in Edmonton (Mind-body intervention with 1-1 support from study personnel)

    Completed
    • Primary Biliary Cirrhosis
    • Mind-body intervention with 1-1 support from study personnel
    • Edmonton, Alberta, Canada
      University of Alberta
    Aug 2, 2022

    Primary Biliary Cholangitis (PBC), Liver Cirrhosis, Biliary Trial in Bunkyo-Ku, Fukuoka (OP-724)

    Completed
    • Primary Biliary Cholangitis (PBC)
    • Liver Cirrhosis, Biliary
    • Bunkyō-Ku, Tokyo, Japan
    • +1 more
    Jul 4, 2022

    Primary Biliary Cholangitis Trial in Indianapolis (Saroglitazar Magnesium 1 mg, Saroglitazar Magnesium 2 mg, Placebo)

    Recruiting
    • Primary Biliary Cholangitis
    • Saroglitazar Magnesium 1 mg
    • +2 more
    • Indianapolis, Indiana
      Zydus site 1
    Apr 28, 2022

    Primary Biliary Cholangitis Trial in Suzhou ([14C]CS0159)

    Not yet recruiting
    • Primary Biliary Cholangitis
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Oct 18, 2023

    Primary Biliary Cholangitis Trial in Beijing (ursodeoxycholic acid)

    Recruiting
    • Primary Biliary Cholangitis
    • ursodeoxycholic acid
    • Beijing, China
      Peking Union Medical College Hospital
    Apr 28, 2022

    Primary Biliary Cholangitis Trial (ASC42 5 mg, ASC42 10 mg, ASC42 15 mg)

    Not yet recruiting
    • Primary Biliary Cholangitis
    • ASC42 5 mg
    • +3 more
    • (no location specified)
    Mar 9, 2022

    Evaluate Effectiveness of OCA on Hepatic Outcomes in PBC

    Completed
    • Primary Biliary Cholangitis
    • Obeticholic Acid 5 MG
    • +2 more
    • San Diego, California
      Intercept Pharmaceuticals, Inc
    Jul 30, 2022

    Primary Biliary Cirrhosis Trial in Edmonton (Mind-body therapy)

    Active, not recruiting
    • Primary Biliary Cirrhosis
    • Mind-body therapy
    • Edmonton, Alberta, Canada
      University of Alberta
    Apr 1, 2022

    Primary Biliary Cholangitis, Primary Biliary Cirrhosis, Cholangitis Trial in United States (HTD1801 (BUDCA))

    Completed
    • Primary Biliary Cholangitis
    • +5 more
    • HTD1801 (BUDCA)
    • Miami, Florida
    • +11 more
    Jun 24, 2022

    Primary Biliary Cholangitis Trial in United States (CNP-104, Placebo)

    Recruiting
    • Primary Biliary Cholangitis
    • Coronado, California
    • +18 more
    Jan 19, 2023

    Primary Biliary Cholangitis Trial in Australia, New Zealand, United States (APD334)

    Terminated
    Has Results
    • Primary Biliary Cholangitis
    • Sacramento, California
    • +8 more
    Feb 28, 2022

    Primary Biliary Cholangitis Trial in Shanghai (CS0159, Placebo)

    Recruiting
    • Primary Biliary Cholangitis
    • Shanghai, China
      Shanghai Xuhui Central Hospital
    Dec 29, 2022

    Primary Sclerosing Cholangitis, Ulcerative Colitis, Biliary Tract Diseases Trial in Prague (Gluten-free diet)

    Recruiting
    • Primary Sclerosing Cholangitis
    • +4 more
    • Gluten-free diet
    • Prague, Czechia
      Institute of clinical and experimental medicine
    Sep 6, 2023

    Primary Biliary Cholangitis, Heart Failure, Obesity Trial in Edmonton (Online mind-body wellness program, Online mind-body

    Recruiting
    • Primary Biliary Cholangitis
    • +9 more
    • Online mind-body wellness program
    • Online mind-body wellness program + Weekly Check-ins
    • Edmonton, Alberta, Canada
      University of Alberta
    Mar 27, 2023

    Hepatitis, Autoimmune, Cholangitis, Liver Cirrhosis, Biliary Trial in Chengdu (Ursodeoxycholic acid combination of

    Recruiting
    • Hepatitis, Autoimmune
    • +3 more
    • Ursodeoxycholic acid combination of immunosuppressive agents
    • Ursodeoxycholic Acid
    • Chengdu, Sichuan, China
      West China Hospital
    Oct 26, 2021